Top 11 Must-Know Pharmacy Industry Trends Revolutionizing Healthcare
- SARMLife
- Nov 11, 2024
- 15 min read
Updated: Jul 20
Summary: This article examines the most significant trends in the pharmacy industry that are shaping the future of healthcare, highlighting how pharmacists are at the forefront of change and innovation.
The Future is Now: Key Pharmacy Trends Transforming Care
Pharmacy industry trends are reshaping healthcare and redefining the role of pharmacists. Today's pharmacists, as key players, are leading innovation, transforming care through digital tools, and advancing data-driven strategies.
One of the most significant trends is the shift toward population health and value-based care, where pharmacists play a pivotal role. These trends are redefining the pharmacist's contribution by enhancing medication adherence, optimizing therapeutic outcomes, and promoting healthcare cost efficiency.
This transformation underscores the increasing integration of pharmacists into multidisciplinary care teams, thereby expanding their impact on patient outcomes on a broader scale and empowering them to make a significant difference in healthcare.
Additional trends in the pharmacy industry, such as telepharmacy, AI-powered pharmacogenomics, and digital pharmacy tools, are accelerating the shift toward personalized and efficient care, offering a promising future for patient care.
This article examines the most significant trends in the pharmacy industry that are shaping the future of healthcare, highlighting how pharmacists are at the forefront of change and innovation.
Historical Trends in the Pharmaceutical Industry
The pharmaceutical industry, as we know it today, has its roots in ancient civilizations where plants and minerals were used for medicinal purposes. However, the modern era of the pharmaceutical industry began in the 19th century, with the isolation and purification of active compounds from natural sources, resulting in more potent and standardized medicines.
For example, in the early 19th century, Friedrich Sertürner isolated morphine from opium, marking a significant milestone in the development of pain management.¹⁵
Other significant advancements include:
Alexander Fleming's discovery of penicillin in 1928 revolutionized the treatment of bacterial infections, marking the beginning of the antibiotic era.⁷
The isolation of insulin by Frederick Banting and Charles Best in 1921 transformed diabetes care.⁷
The identification of thiamine helped combat beriberi.²⁰
The discovery of thiazide diuretics followed the emergence of modern disease classification.²⁹
The development of captopril in the 1980s was modeled after snake venom.⁵
The rise of immunotherapy in the early 2000s reshaped cancer treatment.⁶
The 1961 FDA Amendments, following the Thalidomide scandal, required proof of efficacy and full disclosure of side effects.²³
The late 19th and early 20th centuries witnessed the establishment of major pharmaceutical companies, including Bayer, Merck, and Pfizer. These companies played a crucial role in developing new drugs and advancing medical science.
Which medication is most closely associated with DPYD polymorphism-related toxicity?
A) Imiquimod
C) Methotrexate
B) Leflunomide
D) Capecitabine
Value-Based Pharmaceutical Innovation in VBC Models
As the pharmaceutical industry has evolved, so too has its role in delivering healthcare.
From early breakthroughs like penicillin and insulin to the rise of modern immunotherapy and regulatory advancements, pharmacy has continually adapted to meet the evolving needs of a changing healthcare landscape.
Now, the industry is undergoing another transformative shift, one that extends beyond drug discovery and development. Today, pharma industry trends are increasingly focused on how medications are accessed, managed, and optimized at the population level.
This evolution lays the foundation for value-based care (VBC), where pharmacy's role is to expand the focus on patient-centered outcomes, health equity, and system accountability.
A key mechanism supporting this shift is the adoption of Value-Based Pharmaceutical Contracts (VBPCs), which are performance-based agreements between pharmaceutical manufacturers and payers that link drug reimbursement to clinical outcomes, cost savings, or both.¹⁴
VBPCs align financial incentives with real-world performance, supporting broader payer strategies, such as formulary optimization and patient access initiatives.¹⁴ When thoughtfully designed, these contracts enhance access, promote adherence, and lower the total cost of care by supporting medications with proven long-term value, such as those that prevent hospitalizations or reduce adverse events.¹⁴
VBPCs represent a strategic complement to payer-provider arrangements, demonstrating how pharmacy is becoming an integral driver of performance-based, population health-focused care delivery.²⁷
While VBPCs reflect how pharmaceutical companies are rethinking the value of drugs and reimbursement, population health pharmacy demonstrates how pharmacists are reshaping the delivery of care.
Population Health Pharmacy: A Growing Trend in Pharmacist-Led Care
Population health is a strategic framework for improving outcomes across defined groups by addressing systemic barriers, managing chronic disease, and applying data-informed solutions. As this model gains traction, pharmacists are translating its principles into practice through early intervention, medication access, and care coordination.
Pharmaceutical companies are also contributing to this shift by advancing clinical research that more accurately reflects real-world populations. Together, these actions lead to more equitable, evidence-based care that prioritizes population-level impact.
Now, a more specialized application is emerging through population health pharmacy, a pharmacist-led approach grounded in system-level strategy. Pharmacists in managed care, health systems, and public health roles are leading targeted interventions that improve outcomes and support sustainable, patient-centered care.
In the sections that follow, we explore how population health pharmacy principles are applied in practice, beginning with their role in advancing health equity. This is followed by examples among older adults and patients with complex conditions, such as cancer, where targeted strategies and system-level alignment are most crucial.
Read More: Explore aPHP's blog, "Population Health Pharmacy 101: Elevating Whole-Person Care."
Pharmaceutical Industry Trends Advancing Health Equity
Pharmacists have long been essential to care delivery, and their role continues to expand through population health strategies that enhance adherence, reduce disparities in historically underserved areas, and improve outcomes across entire patient populations.
As the industry shifts from fee-for-service to value-based care (VBC), healthcare and pharma companies are integrating pharmacists into models that reward outcomes over volume. This transition prioritizes cost efficiency, quality improvement, and equitable access, making pharmacy-driven interventions more vital than ever.
Healthcare equity remains a cornerstone of population health, and pharmaceutical companies are aligning with this shift. For example, Johnson & Johnson has launched global initiatives to expand access to innovative therapies in underserved communities, part of a broader effort to reduce disparities and embed equity into both care and innovation strategies.
Key Pharmacy Industry Trends in Personalized and Digital Care
As value-based care and population health strategies continue to transform pharmacy practice, other trends within the pharmacy industry are also driving innovation.
These trends are reshaping how pharmacists oversee medication therapies, how patients engage with care, and how pharmacists apply clinical insight in evolving care models.
From artificial intelligence and digital pharmacy to pharmacogenomics and personalized medicine, these developments reflect the industry's shift toward more efficient, precise, and patient-centered care.
Below are eight additional trends in the pharmacy industry that are currently influencing the profession.
Trend in Medication Cost Optimization.
The high cost of prescription medications remains a significant barrier to health equity. It compromises patient access and contributes to poor medication adherence, undermining both public health efforts and pharmaceutical innovation.
Since the passage of the Inflation Reduction Act (IRA) in 2022, several reforms have focused on improving the affordability of medications, especially for Medicare beneficiaries.¹ These include reducing drug prices and capping out-of-pocket expenses.
At the same time, pharmaceutical companies face increasing pressure to contain costs while maintaining their research pipelines. Reducing drug prices raises critical questions about how to balance affordability with the financial demands of manufacturing, operations, and innovation.
For example, in 2023, Paul Hudson of Sanofi announced that the company would deepen its investments in research and development (R&D) and optimize its cost structure to unlock up to €2 billion in savings from 2024 through 2025, with most of the savings reinvested to support innovation and long-term growth.²⁶
To achieve cost efficiency, some companies are streamlining their clinical trial strategies, prioritizing pivotal research, and accelerating the time to market. Others are exploring value-based pricing, where the price of a drug is directly tied to its clinical effectiveness and real-world outcomes.
Together, these strategies reflect a broader shift toward cost optimization that supports access, equity, and innovation.⁷ This alignment is critical to the future of pharmaceutical care.
Pharmacogenomics Trend.
Pharmacogenomics is a growing field that hopes to bring a personalized approach to medicine. It is a combination of pharmacology and genomics that illustrates how a person's genetic makeup influences their response to medications.²⁴
It is an aspect of precision medicine where experts incorporate genetics, environment, and lifestyle into the development of new drugs and treatment options for targeted therapies.¹⁹
There are some concerns about the complexity of the human genome, but as technology advances, so does our understanding of human genetics. It's safe to say that what we knew of genetics ten years ago compared to today is enough proof.
The application of pharmacogenomics in pharmacy practice will, among other benefits, help optimize clinical trial outcomes and enhance treatment efficacy.
Trends in Patient Engagement.
There will be and continue to be an increased focus on patient engagement in treatment, as well as the development of new drugs.
According to a medical futurist, patients who have had prior exposure to a particular drug should be included on pharmaceutical companies' advisory boards to facilitate improvements in the drug.
This rings true because understanding the customer's needs and preferences is crucial to the success of these pharma companies, as it enhances customer loyalty.
The focus on customer-centric care extends beyond the development of drugs to encompass patients' interactions with the healthcare system and their overall medical experience.²¹
mRNA Vaccine Development for Several Diseases Trend.
Precision medicine strategies, such as pharmacogenomics, are just one aspect of how our increasing understanding of genetics influences relevant industry changes.
Following the success of the first licensed mRNA vaccine against COVID-19, there has been a surge in research into how mRNA technology can be integrated into vaccines.¹⁶
We can expect to see significant progress in developing mRNA vaccines against various diseases, including influenza, HIV, tuberculosis, and rabies.¹⁷
Unlike traditional vaccines, which introduce a weakened or inactivated virus into the body, mRNA vaccines instruct our cells to produce specific proteins from the genetic material of the virus.
This innovative approach triggers our immune system to recognize and combat the actual virus more efficiently. By directly instructing our cells to create the target proteins, mRNA vaccines offer a faster and more precise way to boost our immune defenses.
Trend in Practical Applications of Artificial Intelligence.
Artificial intelligence (AI) is redefining pharmacy innovation, offering real-time tools that enhance clinical decision-making, streamline operations, and personalize patient care.
For example, AI-powered systems can automate routine pharmaceutical tasks, such as prescription filling, inventory management, and claims processing, freeing pharmacists to focus on more complex and value-added activities.¹²
Another significant application of AI in pharmacy practice is analyzing vast patient data in electronic health records (EHRs) to identify potential drug interactions, allergies, and contraindications.
An example is Arine, an AI-powered platform that combines artificial intelligence with clinical expertise for more comprehensive medication management.³ It analyzes patient data to determine who is most at risk because its goal is to provide the proper treatment at the right time.³
This enables pharmacists to provide more accurate and personalized medication recommendations, reducing the risk of adverse drug events.
Leveraging real-world data (RWD) and real-world evidence (RWE) from clinical practice enables the identification of trends and assessment of treatment effectiveness, providing data-driven insights into disease progression that can be used to improve patient outcomes.¹⁰
Digital Pharmacy Improvement Trends.
Over the past two to three years, the healthcare industry has undergone rapid changes due to digitization. This has led to the integration of digital technologies into pharmacy practice, evolving into what is now known as digital pharmacy, a key area of growth in current pharmacy technology trends.
The digital pharmacy ecosystem now includes everything from digital pharmacy apps and bright pill dispensers to drones and e-prescriptions.⁹ These tools reflect several fast-moving trends in digital pharmacy aimed at improving efficiency, adherence, and patient outcomes.
The most common pharmacist-driven trends in this space include telepharmacy services, smart devices powered by the Internet of Things (IoT), advancements in AI-powered e-prescription systems, and the integration of artificial intelligence and robotics into medication management.
Recent advances in digital pharmacy include IoT devices that track health indicators in real-time, automated medication and refill reminders, and telepharmacy platforms that support virtual consultations. These innovations support the broader digital transformation in pharmacy while expanding the role of pharmacists in virtual care.
We also offer remote patient monitoring platforms, such as Smart Meter, that combine real-time data collection with seamless integration across several platforms.²⁸ For example, if a patient’s data readings are out of range, a Hi-Lo Alert Dashboard is available to inform relevant providers in the event of an emergency.
Trends in the Evolving Role of Pharmacists.
A pharmacist’s role is rapidly evolving, extending far beyond traditional dispensing duties.¹² As healthcare becomes increasingly complex, pharmacists are assuming a more active role in patient care, leveraging pharmacy technology trends and innovation to enhance health outcomes.
One significant development in recent years has been the expansion of clinical pharmacy services, a trend that pharmacists must closely follow. Pharmacists now offer a wide range of clinical services, including medication therapy management, immunization administration, and chronic disease management, many of which are delivered through telepharmacy platforms to increase accessibility and reach.
As digital transformation accelerates, pharmacists are embracing emerging trends in pharmacy practice by integrating artificial intelligence, machine learning, and big data analytics into their everyday care. These tools are used to improve medication safety, optimize drug therapy, and detect potential drug interactions. They also support personalized care planning aligned with population health pharmacy strategies.
In this environment, pharmacists will play an increasingly important role in improving patient outcomes and reducing healthcare costs. Their integration into digital care models and population health teams underscores a broader shift toward pharmacist-driven trends that prioritize data-informed, equitable care delivery.
Trend in Geriatric Pharmacotherapy.
Knowledge of geriatric pharmacotherapy ranks among the top trends in the pharmacy industry, especially within population health pharmacy. Safe medication use in older persons is a growing public health priority. Older adults use the most medications and face the highest risks from adverse drug events, inappropriate prescribing, and polypharmacy. This demands specialized pharmacist expertise grounded in system-level thinking and individualized risk assessment.
Clinical Tools that Guide Safer Prescribing
To support this expertise, clinical guidelines such as the American Geriatrics Society Beers Criteria (commonly referred to as the American Geriatric Society (AGS) Beers Criteria®) and the START/STOPP criteria help optimize medication safety and appropriateness.¹¹ ²² The Beers Criteria flags potentially inappropriate medications (PIMs), while START/STOPP also identifies missed prescribing opportunities, making both essential tools for pharmacists caring for older adults.²²
Health System Application in Action
Building on these tools, health systems are beginning to operationalize this expertise. For example, the Cleveland Clinic embedded a geriatric pharmacy specialist into its population health team to lead deprescribing initiatives, improve chronic disease management, and reduce emergency department utilization.⁴ This model shows how the pharmacy's role in population health directly enhances care for older adults.
Industry Investment Signals a Strategic Shift
In a $550 million collaboration with BioAge Labs, Novartis is investing in aging research and the development of drugs related to the aging process.¹⁸ This reinforces a broader trend in pharmacy practices that prioritizes innovation in geriatric care and therapeutic longevity. Pharmacists with advanced training in geriatric care are essential to guiding the safe and effective implementation of these future therapies.
The Population Health Opportunity
As value-based care evolves, pharmacists trained in geriatric pharmacotherapy are positioned to drive safe, targeted interventions that reduce risks and support improved outcomes for older adults across healthcare settings.
Oncology and Specialty Pharmacy Trends.
The growth of specialty pharmacies, particularly in oncology, is transforming the role of pharmacies in delivering high-cost care. As cancer therapies remain the top driver of medical benefit spending across commercial, Medicare, and Medicaid plans, the demand for pharmacists trained in oncology and population health continues to rise.
According to the American Society of Clinical Oncology (ASCO), total cancer care costs are projected to reach $246 billion by 2030, a 34 percent increase from 2015.¹³ This rise reflects the expansion of access, the increasing cost of immunotherapies, and the growing pipeline of novel agents.
At the same time, Prime Therapeutics’ 2023 Medical Pharmacy Trend Report confirms that oncology leads per-member-per-month (PMPM) spend across all payer lines.²⁵ High-cost drug utilization grew by double digits in both commercial and Medicare plans, and job trends reflect this shift.²⁵ Health systems and payers are hiring pharmacists with oncology clinical skills to improve care navigation, manage biosimilars, reduce waste, and support value-based cancer care models.
Pharmacists trained in oncology population health strategy bring critical value to care teams. Their role includes optimizing adherence, guiding formulary decisions, and enhancing cost efficiency across oncology services.
Dr. La Kesha Y. Farmer, founder of aPHP, has implemented and led an oncology population health initiative for Medicaid members, focusing on the roles of pharmacists in improving outcomes and reducing hospitalization risk. One key strategy involved targeting members on new treatment regimens to prevent adverse events and support continuity of care. The insight shared below highlights one of the key lessons from this initiative.
How to Stay Updated on Current Pharmacy Trends
Here are some practical ways you can stay updated on pharmacy industry trends:
Membership in Professional Organizations.
Joining professional organizations, such as the American Pharmacists Association (APhA) or the National Association of Chain Drug Stores (NACDS), provides access to valuable resources, networking opportunities, and the latest industry news.
Subscribe to Relevant Newsletters.
Subscribing to industry newsletters like Drug Topics, Managed Healthcare Executive, and Pharmacy Times will help you stay informed about the latest trends, research, and regulatory updates.
Follow the Right Pharmacy Blogs.
Pharmacy blogs and websites, such as Pharmacy Times, Drug Topics, the American Society of Health-System Pharmacists (ASHP), and The Academy of Population Health Pharmacy (aPHP), provide insights into current trends and best practices.
Join Relevant Pharmacy Communities.
Joining online communities and forums, such as verified LinkedIn pharmacy groups, allows you to connect with peers, share knowledge, and discuss industry trends.
Attend Conferences and Webinars.
Attending industry conferences and webinars allows you to learn from experts, network with colleagues, and stay up-to-date on the latest research and developments. Symposiums such as the Deprescribing Guideline Symposium and webinars at GeriatricsCareOnline support ongoing efforts to improve care for older adults.
Leverage Continuing Education for Pharmacists.
Most continuing education courses for pharmacists focus on current trends and practices in the industry. Participating in these programs helps you maintain your license and stay current on the latest advancements in pharmacy practice.
Read Research Journals.
Research journals, such as the Journal of the American Pharmacists Association (JAPhA) or the American Journal of Health-System Pharmacy (AJHP), inform pharmacists about the latest scientific findings and clinical research.
Monitor Regulatory Changes.
Monitoring regulatory changes from agencies like the FDA and DEA is crucial for ensuring compliance and providing safe and effective patient care.
In January 2025, the FDA released final guidance on Predetermined Change Control Plans (PCCPs) for artificial intelligence-enabled device software functions (AI-DSFs).³⁰ The guidance outlines how manufacturers may plan, validate, and implement AI-driven software modifications while maintaining safety and effectiveness.
Take note: This shift reflects the FDA’s broader strategy to support iterative improvements in AI-enabled technologies with minimal regulatory burden. Pharmacists working in digital health, clinical informatics, or regulatory affairs should stay informed, as AI-driven devices continue to integrate with population health and medication management systems.
Embracing Change: Pharmacy Trends & The Future of Patient Care
It’s an exciting time to be part of the pharmacy industry. From personalized medicine and telepharmacy to AI-powered drug discovery and advanced automation, the field is undergoing rapid transformation.
Pharmacy industry trends are reshaping the healthcare landscape, ushering in a future defined by innovation, equity, and patient-centered care. Central to this shift is the integration of population health and value-based care models, where pharmacists drive improved outcomes through prevention, data-driven interventions, and collaboration at the system level.
As the industry evolves, staying informed and adapting to emerging trends is crucial. By embracing these changes, pharmacists expand their impact, enhance care delivery, and drive progress in a value-focused healthcare system.
Remember, continuous learning is the foundation for success in this dynamic environment, and CE courses for pharmacists make it possible. Let’s stay engaged, adapt with purpose, and continue delivering exceptional care to our communities.
Answer to quiz question#1: (D) Capecitabine.
References
Alpha-Sense. "Inflation Reduction Act: What We Know One Year In." Alpha-Sense.com, 2022, www.alpha-sense.com/blog/trends/inflation-reduction-act-one-year-in/. Accessed 11 Nov 2024.
Alpha-Sense. "Top Pharma Industry Trends to Watch in 2023." Alpha-Sense.com, 30 Aug. 2023, www.alpha-sense.com/blog/trends/pharma-industry-trends/. Accessed 11 Nov 2024.
Arine. "Comprehensive Medication Management." Arine.io, 2024, www.arine.io/.
Ayers, Gina, and Ardeshir Hashmi. “Enhancing Population Health with Integration of a Geriatric Pharmacy Specialist.” Consult QD – Cleveland Clinic, 25 Jan. 2019, https://consultqd.clevelandclinic.org/enhancing-population-health-with-integration-of-a-geriatric-pharmacy-specialist.
Bryan, Jenny. “From Snake Venom to ACE Inhibitor — the Discovery and Rise of Captopril.” The Pharmaceutical Journal, 17 Apr. 2009, pharmaceutical-journal.com/article/news/from-snake-venom-to-ace-inhibitor-the-discovery-and-rise-of-captopril.
Dobosz P, Dzieciątkowski T. "The Intriguing History of Cancer Immunotherapy." Front Immunol. 2019 Dec 17;10:2965. https://doi: 10.3389/fimmu.2019.02965.
Encyclopedia Britannica. "Pharmaceutical Industry - Transitions in Drug Discovery." Encyclopedia Britannica, www.britannica.com/technology/pharmaceutical-industry/Transitions-in-drug-discovery. Accessed 11 Nov 2024.
European Pharmaceutical Review. "2024 Pharmaceutical Industry Trends." European Pharmaceutical Review, 29 Apr. 2024, www.europeanpharmaceuticalreview.com/article/215203/2024-pharmaceutical-industry-trends-discover-the-latest-pharma-quality-and-manufacturing-trends/.
Furman, Oleksandra. “Digital Pharmacy: Key Trends, Challenges, and Success Stories.” Blog - Mind Studios, Mind Studios, 7 Mar. 2024, themindstudios.com/blog/digital-pharmacy-software-development/.
Global Pharma Tek. "Exploring the Future: Top Pharmaceutical Industry Trends in 2024." Global Pharma Tek, 4 Jan. 2024, www.globalpharmatek.com/blog/top-12-pharmaceutical-industry-trends-in-2024/.
Greenberg, Sherry A. “The 2023 American Geriatrics Society Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults.” Journal of the American Geriatrics Society, vol. 71, no. 7, 2023, pp. 2052–2081, https://doi.org/10.1111/jgs.18372.
lhogan. “2024 Pharmacy Trends to Look For.” Digital Pharmacist, 22 Dec. 2023, www.digitalpharmacist.com/blog/2024-pharmacy-trends-to-look-for/. Accessed 9 July 2025.
Junk, Christopher, et al. “Changes in Oncology Pharmacy Benefit Drug Spend and Trend in the United States.” Journal of Clinical Oncology, vol. 40, no. 16_suppl, 1 June 2022, pp. e18832–e18832, https://doi.org/10.1200/jco.2022.40.16_suppl.e18832. Accessed 9 July 2025.
Kannarkat et al. “Value-Based Pharmaceutical Contracts: Value for Whom?” Value in Health, vol. 23, no. 2, 2020, pp. 154–156. Elsevier, https://doi.org/10.1016/j.jval.2019.10.009.
Krishnamurti C, Rao SC. "The isolation of morphine by Serturner." Indian J Anaesth. 2016 Nov;60(11):861-862. https://doi: 10.4103/0019-5049.193696.
Kruglyak, Igor. “Pharmaceutical Industry in 2021: Top 11 Pharma Trends.” Avenga, 18 Jan. 2021, www.avenga.com/magazine/pharmaceutical-industry-trends/.
Matarazzo L, Bettencourt PJG. "mRNA vaccines: a new opportunity for malaria, tuberculosis, and HIV." Front Immunol. 2023 Apr 24;14:1172691. https://doi: 10.3389/fimmu.2023.1172691.
MedPath. “Novartis Invests in Aging Research: A $550 Million Bet on the Future of Drug Development.” MedPath, 23 May 2025, trial.medpath.com/news/ac10f2a275c639f4/novartis-invests-in-aging-research-a-550-million-bet-on-the-future-of-drug-development. Accessed 9 July 2025.
National Human Genome Institute (NHGI). “Precision Medicine.” NHGI, Genome.gov, www.genome.gov/genetics-glossary/Precision-Medicine. Accessed 9 July 2025.
Nobel Prize. “Christiaan Eijkman, Beriberi and Vitamin B1.” Educationalgames.nobelprize.org, educationalgames.nobelprize.org/educational/medicine/vitamin_b1/eijkman.php. Accessed 11 Nov 2024.
Núria, Emilio. “Pharmaceutical Industry Trends 2024 - 2025.” Bismart.com, Bismart, 12 June 2024, blog.bismart.com/en/pharmaceutical-industry-trends. Accessed 11 Nov 2024.
O’Mahony D, Cherubini A, Guiteras AR, et al. "STOPP/START criteria for potentially inappropriate prescribing in older people: version 3." Eur Geriatr Med. 2023;14(4):625-632. https://psnet.ahrq.gov/issue/stoppstart-criteria-potentially-inappropriate-prescribing-older-people-version-3.
Pharmaphorum. "A History of the Pharmaceutical Industry." Pharmaphorum, 1 Sept. 2020, pharmaphorum.com/r-d/a_history_of_the_pharmaceutical_industry. Accessed 11 Nov 2024.
Pirmohamed M. "Pharmacogenetics and pharmacogenomics." Br J Clin Pharmacol. 2001 Oct;52(4):345-7. https://doi: 10.1046/j.0306-5251.2001.01498.x.
Prime Therapeutics. "AIS Health: Prime Report: Oncology Medical Benefit Drugs Continue to Drive Trend." Prime Therapeutics, 2024, www.primetherapeutics.com/w/prime-report-oncology-medical-benefit-drugs-continue-to-drive-trend. Accessed 9 July 2025.
Sanofi. “Press Release: Sanofi Enters Next Chapter of Play to Win Strategy.” Www.sanofi.com, 27 Oct. 2023, www.sanofi.com/en/media-room/press-releases/2023/2023-10-27-05-30-00-2768148. Accessed 11 Nov 2024.
Scotti, Samantha. “Value-Based Care in the Commercial Sector and with Multi-Payer Arrangements.” Www.ncsl.org, 9 Jan. 2024, www.ncsl.org/health/value-based-care-in-the-commercial-sector-and-with-multi-payer-arrangements.
Smart Meter. “Solutions - Smart Meter.” Smart Meter, 30 Apr. 2025, smartmeterrpm.com/rpm-solutions/. Accessed 9 July 2025.
The National Inventors Hall of Fame®. “James Sprague." The National Inventors Hall of Fame®.” Invent.org, 9 July 2025, www.invent.org/inductees/james-sprague. Accessed 9 July 2025.
U.S. Food and Drug Administration. "Webinar - Predetermined Change Control Plans for AI-Enabled Devices." U.S. Food and Drug Administration, 2025, www.fda.gov/medical-devices/cdrhnew-news-and-updates/webinar-final-guidance-marketing-submission-recommendations-predetermined-change-control-plan. Accessed 9 July 2025.